Clinical Trial Update: Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis [Phase 2]

View source ↗

Summary

ACELYRIN's Phase 2b pivotal study of Izokibep for non-infectious uveitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Izokibep (izokibep)

Snippet

Sponsor: ACELYRIN Inc. | Conditions: Uveitis | Phase 2 | Status: TERMINATED